In 2013, Tzartos et al. [55] used various methods to detect serum antibodies against AQP1 in patients with NMOSD phenotype including the core clinical characteristics of LETM and/or optic neuritis, according to the 2015 NMOSD criteria [15]. The gene discussed is AQP1; the disease is optic neuritis.